Last reviewed · How we verify
Meningococcus carrier
Approved treatments
- Rifadin · Sanofi Aventis Us
- Minocycline Hydrochloride · Rempex
MINOCYCLINE works by inhibiting protein synthesis in bacteria, ultimately leading to their death. - Minocyclin · University of Southern California
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Meningococcus carrier patent landscape — cliff calendar, originator estates, attackable patents
- Meningococcus carrier treatment landscape brief
- Meningococcus carrier treatment updates RSS
Frequently asked questions about Meningococcus carrier
What drugs treat Meningococcus carrier?
Tracked treatments include Rifadin, Minocycline Hydrochloride, Minocyclin.
What is the treatment for Meningococcus carrier?
Standard treatment for Meningococcus carrier includes Rifadin, Minocycline Hydrochloride, Minocyclin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Meningococcus carrier patent cliff · Meningococcus carrier CI report
- Treatment: Rifadin · Sanofi Aventis Us
- Treatment: Minocycline Hydrochloride · Rempex
- Treatment: Minocyclin · University of Southern California
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing